Observational case series on the clinical performance of the Variable Angle Clavicle Plate and Clavicle Hook Plate 2.7 systems: a study protocol
Clicks: 3
ID: 310157
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #419 of 490 articles by views in Frontiers in surgery
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 490 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BackgroundReoperation rates in clavicular fractures and acromioclavicular (AC) joint dislocations are high, often indicated for plate removal due to plate prominence and poor cosmesis. The recently designed 2.7 mm variable angle locking compression plate (VA-LCP®) Clavicle Plate and 2.7 mm VA-LCP® Clavicle Hook Plate (J&J MedTech) are intended to have an improved plate-to-bone fit, are precontoured, and have a low profile. Additionally, the Clavicle Hook Plate has a more anatomically adapted hook design to reduce the risk of painful osteolysis leading to earlier plate removals. All screw holes in these plates accept 2.7 mm screws. Primary objectives of this observational, post-marketing, prospective, multicenter case series are to gather early and mid- to long-term evidence on the clinical performance, safety, and usability of the 2.7 mm VA-LCP Clavicle Plates and 2.7 mm VA-LCP Clavicle Hook Plates, specifically to describe (1) safety, (2) clinical performance, (3) functional outcomes, (4) patient-reported outcomes (PROs) and (5) usability and surgeons' experience with the devices.MethodsApproximately 76 patients with clavicle fractures and primary surgical treatment with the 2.7 mm VA-LCP Clavicle Plate or 2.7 mm VA-LCP Clavicle Hook Plate will be enrolled prospectively over 15 months. Outcome measures include adverse events related/potentially related to the investigational device, clinical performance, functional outcomes (QuickDASH), PROs (PROMIS® upper extremity score, local pain, discomfort, and plate prominence), and radiographic outcomes. Data will be collected at baseline, 2w, 6w, 3m, 6m, 1y and 2y after surgery. The surgeons' experience with and perceived utility of the devices will be surveyed. Interim analysis will be performed when 30 patients per group have reached 6 months after surgery. Long-term outcomes will be evaluated using 2-year follow-up results. A Statistical Analysis Plan will be prepared before final analysis summarizing the descriptive statistics to be used.DiscussionThe study described in this protocol on patients with clavicular fracture or AC joint dislocations undergoing surgical fracture fixation aims to gather first evidence on the clinical performance, safety, and usability of the 2.7 mm VA-LCP Clavicle Plates and 2.7 mm VA-LCP Clavicle Hook Plate Systems. This study will provide valuable data from a standard-of-care setting and may help design future comparative studies for relevant performance parameters.Clinical Trial Registrationhttps://clinicaltrials.gov/study/NCT04921865?term=NCT04921865%20&rank=1, identifier NCT04921865.
| Reference Key |
imported_1768922240_696f9c8058b27
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lambert, Simon |
| Journal | Frontiers in surgery |
| Year | 2026 |
| DOI |
10.3389/fsurg.2025.1694295
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.